Form 4 for ICCC IMMUCELL CORP /DE/
Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-02 · accession 0001437749-25-036794 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-03 | 2025-12-02+ | ICCC | te Boekhorst Paul Francis Olivier | Pres, CEO, Dir | P - Purchase | $4.97 | +9,785 | 9,785 | New | +$48.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock $0.10 par value per share | 2025-12-02 | P | A | 3,708 | $4.87 | 3,708 | D | — | — | |
| 2 | Common | Common Stock $0.10 par value per share | 2025-12-03 | P | A | 2,556 | $5.00 | 6,264 | D | — | — | |
| 3 | Common | Common Stock $0.10 par value per share | 2025-12-03 | P | A | 3,521 | $5.04 | 9,785 | D | — | — |